About Kalytera Therapeutics
Kalytera Therapeutics is a company based in San Rafael (United States) founded in 2014 by David Stefansky.. Kalytera Therapeutics has completed 2 acquisitions, including Salzman Group and Talent Biotech. Kalytera Therapeutics operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.
- Headquarter San Rafael, United States
- Founders David Stefansky
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Salzman Group
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Kalytera Therapeutics
- Total Funding Total Funding
- Total Rounds 12
- Last Round Last Round
-
First Round
First Round
(29 Jul 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Post-IPO - Kalytera Therapeutics | Valuation |
investors |
|
| Oct, 2019 | Amount | Post-IPO - Kalytera Therapeutics | Valuation |
investors |
|
| Oct, 2019 | Amount | Post-IPO - Kalytera Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kalytera Therapeutics
Kalytera Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include aphriafuture.ca. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kalytera Therapeutics
Kalytera Therapeutics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Salzman Group and Talent Biotech. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cannabidiol therapies are developed to prevent and treat GvHD.
|
2014 | ||||
|
Small molecule therapeutics for Crohn's disease are developed.
|
1996 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Kalytera Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kalytera Therapeutics Comparisons
Competitors of Kalytera Therapeutics
Kalytera Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| domain | founded_year | HQ Location |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| domain | founded_year | HQ Location |
Medical cannabis products are provided based on GMP processes.
|
|
| domain | founded_year | HQ Location |
Plant-derived cannabinoid products are developed for medical and consumer uses.
|
|
| domain | founded_year | HQ Location |
Manufacturer of medicinal cannabis for therapeutic use
|
|
| domain | founded_year | HQ Location |
Developer of medical cannabis products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kalytera Therapeutics
Frequently Asked Questions about Kalytera Therapeutics
When was Kalytera Therapeutics founded?
Kalytera Therapeutics was founded in 2014.
Where is Kalytera Therapeutics located?
Kalytera Therapeutics is headquartered in San Rafael, United States. It is registered at San Rafael, California, United States.
What does Kalytera Therapeutics do?
Kalytera Therapeutics was founded in 2014 in San Rafael, United States, within the biotechnology sector. Cannabinoid-based treatments are advanced for osteoporosis and bone healing applications. A range of non-psychoactive cannabinoids and endocannabinoid-like compounds is included in the portfolio, with emphasis on synthetic options for commercialization. The lead candidate, KAL671a synthetic fatty acid amide licensed from Yissum Research Development Companyis under research to support bone restoration in osteoporosis cases.
Who are the top competitors of Kalytera Therapeutics?
Kalytera Therapeutics's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.
How many acquisitions has Kalytera Therapeutics made?
Kalytera Therapeutics has made 2 acquisitions, including Salzman Group, and Talent Biotech.
Who are Kalytera Therapeutics's investors?
Kalytera Therapeutics has 1 investor. Key investors include aphriafuture.ca.